Blog Archives

Blog

CERTAINTY 2025: The power of Model-Informed Drug Development

We cover the key takeaways from CERTAINTY 2025, including the power of Model-Informed Drug Development…

CertaraMay 16, 2025

Blog Knowledge Base

Extrapolating AUC to Infinity

AUC calculations are simple but nuanced. In this blog, we look at how to extrapolate…

CertaraMay 15, 2025

Blog

QSP Summit 2025: A New Standard in the Future of Drug Development

May 5, 2025 The Quantitative Systems Pharmacology (QSP) Summit 2025, hosted by Certara, marked another…

CertaraMay 5, 2025

Blog

Essentials of Model-informed Drug Development in Oncology

Model-informed drug development in oncology is critical to developing safer and more effective cancer drugs.…

CertaraMay 2, 2025

Blog

SEND V4.0 – What to Expect and When to Expect It

April 24, 2025 As the Standard for Exchange of Nonclinical Data (SEND) continues to evolve…

CertaraApril 24, 2025

Blog

Best Practices for AI Prompt Engineering in Life Sciences

April 23, 2025 Prompt engineering is an emerging skill introduced to the public with the…

CertaraApril 23, 2025

Blog

Managing Clinical Metadata for your Vendors, Studies, and Datasets

April 21, 2025 Clinical research is witnessing an evolution, driven by the increasing complexities of…

CertaraApril 21, 2025

Blog

In case you missed it: CHI + Certara Webinar on Artificial Intelligence (AI) -Powered Model-Informed Drug Development (MIDD)

April 18, 2025 What’s next for drug development? Recapping our MIDD in the age of…

CertaraApril 18, 2025

Blog

Using SDTM Data to Produce Patient Narratives

In this blog, we look at how medical writers can use SDTM data produced by…

CertaraApril 15, 2025

Blog

How to Use Fix Tips for Better Clinical Data Issue Management

April 15, 2025 Prior to submission to any regulatory agency, standardized study data is evaluated using at…

CertaraApril 15, 2025

Blog

CERTAINTY 2025: The power of Model-Informed Drug Development

Extrapolating AUC to Infinity

QSP Summit 2025: A New Standard in the Future of Drug Development

Essentials of Model-informed Drug Development in Oncology

SEND V4.0 – What to Expect and When to Expect It

Best Practices for AI Prompt Engineering in Life Sciences

Managing Clinical Metadata for your Vendors, Studies, and Datasets

In case you missed it: CHI + Certara Webinar on Artificial Intelligence (AI) -Powered Model-Informed Drug Development (MIDD)

Using SDTM Data to Produce Patient Narratives

How to Use Fix Tips for Better Clinical Data Issue Management

Newsletter sign up

Quick links

Solutions

Contact